SCHEMBL3027458

SCHEMBL3027458

CCOC(=O)c1[nH]c(C(=O)O)c(Cl)c1C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
CYP1A2 P05177 3/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 1/20 0.56
CYP2D6 P10635 1/20 0.55
HPGD P15428 4/20 0.53
KMT2A Q03164 3/20 0.47
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3033551 0.93 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL3036660 0.82 CYP1A2 (0.70) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL5322610 0.81 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL11652356 0.81 CYP1A2 (0.80) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL7258093 0.81 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL3110612 0.79 CYP1A2 (0.55) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL24392209 0.77 CYP1A2 (0.67) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL28590481 0.77 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL9424671 0.76 CYP1A2 (0.58) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL7046856 0.76 CYP1A2 (0.71) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 ALDH1A1 348/4885CYP1A2 301/4885CYP2C9 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.